Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Melanoma/Skin Cancer
•
Dermatology
Do computerized mole-mapping tools play a role in your clinical practice?
Are they effective adjuncts in diagnosing atypical pigmented lesions?
Related Questions
Do you obtain MRI for cutaneous SCC with microscopic PNI to assess for gross perineural tumor spread?
Would you favor radiation or immune modulating treatment like imiquimod to treat an uncomplicated basal cell carcinoma on the nose in an elderly patient for whom you'd like to avoid surgery?
What is your experience with itraconazole as a primary or adjunct therapy for individuals with numerous BCCs?
How do you approach patients with advanced resectable basal cell carcinoma for possible use of hedgehog inhibitors?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
Are there certain patient characteristics that drive you to recommend intralesional 5-FU or MTX for a large SCC on the back?
What is the recommended approach for systemic therapy in a patient with metastatic cutaneous squamous cell carcinoma with active autoimmune disease (dermatomyositis)?
What’s your approach to treating multiple facial BCCs in gorlin syndrome?
How do you approach melanoma patients with a positive sentinel node with extra-nodal extension for definitive surgical management?
What biopsy/surgical approach do you take for multiple BAPoma lesions in a patient with BAP1 tumor predisposition syndrome?